Results 41 to 50 of about 8,176 (156)

Rifaximin treatment of pathogen-negative travelers' diarrhea [PDF]

, 2007
BACKGROUND: Antibacterial drugs appear to be effective in shortening the illness of a majority of cases of travelers' diarrhea. METHODS: This was a subanalysis from two randomized, double-blind, placebo-controlled trials in adult travelers with acute
Ericsson, C D, Haake, R, Jiang, Z D, Steffen, R, Taylor, D N, DuPont, H L, Okhuysen, P C   +6 more
core   +1 more source

Sarcopenia Is Associated With Mortality and Progression of Cirrhosis in Decompensated but Not Compensated Disease—A Multicentre Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 1, Page 36-49, July 2026.
In a retrospective cohort of 1,624 adults with cirrhosis, sarcopenia was independently associated with unplanned hospitalization, death, and cirrhosis progression (or death) in patients with decompensated disease. In compensated cirrhosis, sarcopenia was associated only with a higher risk of unplanned hospitalization.
Puneeta Tandon, Sarah Wang, Moon Young Kim, Bart Van Hoek, Daphne Bot, Jeroen L. A. van Vugt, Berend Beumer, Jan Ijzermans, Sunil Taneja, Ajay Duseja, Surender Singh, Maryam Ebadi, Aldo J. Montano‐Loza   +12 more
wiley   +1 more source

Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach [PDF]

, 2015
Sara Soldi,1 Sotirios Vasileiadis,2 Francesca Uggeri,1 Mariachiara Campanale,3 Lorenzo Morelli,4 Maria Vittoria Fogli,5 Fiorella Calanni,5 Maria Grimaldi,5 Antonio Gasbarrini31AAT – Advanced Analytical Technologies Srl, Piacenza, Italy; 2Centre for
Uggeri F, Vasileiadis S, Fogli MV, Gasbarrini A, Soldi S, Campanale M, Morelli L, Grimaldi M, Calanni F   +8 more
core  

A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea [PDF]

, 2006
Rifaximin was compared with placebo and ciprofloxacin for treatment of travelers' diarrhea in a randomized, double-blind clinical trial. Adult travelers (N = 399) consulting travel clinics in Mexico, Guatemala, and India were randomized to receive ...
Rifaximin Study Group, Robert Haake, David N. Taylor, Ericsson, C D, Steffen, R, Jiang, Z D, Robert Steffen, Herbert L. Dupont, Jane Halpern, The, Bourgeois, A L, Halpern, J, Zhi-dong Jiang, Dupont, H L, Haake, R, Taylor, D N, A. Louis Bourgeois, Charles D. Ericsson   +17 more
core   +1 more source

Pre‐TIPS Liver and Spleen Volumetry Are Not Associated With Liver‐Related Outcomes After TIPS Placement for Refractory Ascites

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background & Aims Transjugular intrahepatic portosystemic shunt (TIPS) improves survival in refractory ascites. A careful patient's selection is mandatory as TIPS can lead to complications. Liver volumetry is predictive of outcomes before hepatic surgery, but data on its role before TIPS placement are scarce. We aimed to evaluate whether liver
José Ursic Bedoya, Mathilde Wagner, Emilie Malézieux, Paul Primard, Hélène Larrue, Sarah Mouri, Charlotte Bouzbib, Marion Soler, Christophe Bureau, Nicolas Molinari, Boris Guiu, Marwa Aboudrar, Calvin Mbenda, Charles Roux, Georges‐Philippe Pageaux, Dominique Thabut, Marika Rudler   +16 more
wiley   +1 more source

Rifaximin therapy and hepatic encephalopathy: Pros and cons [PDF]

, 2012
Hepatic encephalopathy (HE) is the second most common major complication in cirrhotics and it significantly impacts quality of life. Therapeutic approaches for HE treatment and prevention mainly continue to rely on ammonia-lowering strategies and non ...
R. Lorenzetti, RIGGIO, Oliviero, RIDOLA, LORENZO, Angelo Zullo, S. m. Campo, C. Hassan, Hassan, Cesare   +6 more
core   +1 more source

Sarcopenia Predicts Mortality and Hepatic Encephalopathy After TIPS in Older Adults With Cirrhosis and Improves Prognostic Scores

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aims The role of transjugular intrahepatic portosystemic shunt (TIPS) in older adults remains controversial because of limited risk‐stratification tools. We aimed to assess whether sarcopenia and myosteatosis are independently associated with post‐TIPS mortality and overt hepatic encephalopathy (OHE) in patients aged ≥ 70 years,
Dario Saltini, Silvia Nardelli, Roberto Miraglia, Davide Roccarina, Stefania Gioia, Federico Banchelli, Luigi Maruzzelli, Cristian Caporali, Gianmarco Falcone, Marcello Bianchini, Tomas Guasconi, Angelica Ingravallo, Simone Di Cola, Rosina Maria Critelli, Fabiola Milosa, Antonio Piscopo, Federico Casari, Andrea Salomé Velasco Mayorga, Filippo Scianò, Giovanni Battinelli, Francesco Ascari, Oliviero Riggio, Fabio Marra, Manuela Merli, Francesco Vizzutti, Filippo Schepis   +25 more
wiley   +1 more source

RIFAXIMIN COMPOSITIONS AND METHOD OF USE [PDF]

, 2008
Forms of rifaximin (INN) antibiotic, such as the poorly crystalline form named rifaximin gamma are described, along with the production of medicinal preparations containing rifaximin for oral and topical ...
CAMPANA M., ROSINI, GOFFREDO, RIGHI, PAOLO, BRAGA, DARIO, CONFORTINI D., CANNATA V., VISCOMI G. C.   +6 more
core  

Encephalopathy: Cause, Pathogenesis, and Treatment

MedComm, Volume 7, Issue 6, June 2026.
Various encephalopathies (sepsis‐associated, hepatic, hypoxic–ischemic, diabetic, uremic, toxic) have incompletely elucidated pathogenesis, which severely restricts targeted therapy development. Small molecule drugs show unique multitarget potential but face toxicity, poor blood–brain barrier penetration and unclear specificity.
Shimeng Lv, Xia Zhong, Ruirui Shang, Linghui Kong, Yufei Huang, Yuexiang Ma, Jing Teng, Sheng Wei   +7 more
wiley   +1 more source

Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. [PDF]

, 2010
BACKGROUND: Abnormal intestinal clearance is involved in the pathogenesis of small intestinal bacterial overgrowth (SIBO). It is known that partially hydrolysed guar gum affects intestinal motility.
Parodi, Andrea, Assandri, Lorenzo, E. Savarino, V. Savarino, E.G. Giannini, Giannini, Edoardo G, Savarino, Vincenzo, A. Parodi, L. Assandri, Gemignani, Lorenzo, Bonfanti, Daria, M. Furnari, S. Marenco, Marenco, Simona, Furnari, Manuele, E. G. Giannini, L. Gemignani, V. Fazio, Savarino, Edoardo, Inferrera, Simona, D. Bonfanti, SAVARINO, EDOARDO VINCENZO, Fazio, Valentina, S. Inferrera   +23 more
core   +1 more source